Subcutaneous Injection
Subcutaneous injection of PT-141 is favored for its high bioavailability and consistent delivery into the bloodstream, bypassing mucosal variability [Doc 2]. This method is typically administered into the lower abdomen or upper thigh using an autoinjector pen or syringe, ensuring precise dosing [Doc 4]. The onset of effects occurs approximately 45 minutes post-injection, with effects lasting 6 to 12 hours, making it suitable for patients with complex erectile dysfunction cases [Doc 4]. The standard dosage ranges from 1.0 to 1.75 mg per dose, with a maximum of two doses per week [Doc 1].
| Phase / Protocol | Dosage | Frequency |
|---|---|---|
| Standard | 1.75 mg | as needed, max 2 doses per week |
Oral Troche
Oral troches of PT-141 are dissolved under the tongue, offering a non-invasive administration route [Doc 1]. This method is convenient and avoids needles, but absorption can be inconsistent due to mucosal health and technique [Doc 1]. The onset of effects is typically within 30 to 45 minutes, with a shorter duration compared to injections [Doc 1]. Dosages range from 0.5 to 1.75 mg per troche, with a maximum of three doses per week [Doc 1].
| Phase / Protocol | Dosage | Frequency |
|---|---|---|
| Standard | 1.75 mg | as needed, max 3 doses per week |
References & Citations
- [1]https://qualiphyknowledgebase.zendesk.com/hc/en-us/articles/34908166327963-Peptide-PT-141-Bremelanotide-Injectable-Oral-Treatment-Protocol
- [2]https://www.paragonsportsmedicine.com/peptides/pt-141
- [3]https://mensreproductivehealth.com/pt-141-for-men-a-new-drug-to-treat-erectile-dysfunction-and-low-libido/
- [4]https://www.bostonmedicalgroup.com/pt-141-nasal-spray-vs-injection-effectiveness/
